|
|
 |
|
Viewing report
|
|
|
|
European Immunodiagnostics Markets
Frost & Sullivan, Jan 1998
The shift away from isotopic technologies in favor of their safer, less-expensive non-isotopic counterparts is reshaping this industry. This report from Frost & Sullivan s team of medical industry experts looks at the ramifications of this transition, and discusses what lies ahead for radioimmunoassay market participants. It also offers a glimpse into the promising future of the chemiluminescent segment. Profiles of top companies like Bayer, Hybritech, Ortho, and Dade-Behring are included.
Customers who bought this item also bought
Immunoassay Systems - Global Strategic Business Report
The 2011 Malaria Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country
The 2011 E. Coli Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country
The 2011 Cryptosporidium Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country
The 2011 Rhinovirus Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country
Immunoassay Instruments - Global Market Trends
The 2011 Therapeutic Drug Monitoring Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country and Market Segment
The 2011 Syphilis Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country
The 2011 CMV Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country
The 2011 Gonorrhea Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country
|
|
|
|
